Bellon Steven F.
SEC CIK 1831749 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc. | CSO | 102.0K | — | $190.0K | 3 | 2022-05-25 | 2024-09-09 |
Most active insiders at FHTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GOTTSCHALK ADRIAN | CEO, Dir | — | — |
Bellon Steven F. made no open-market trades at FHTX in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-09-11 | 2024-09-09 | FHTX | Foghorn Therapeutics Inc. | Bellon Steven F. | CSO | S - Sale | $9.50 | -20.0K | 102.0K | -16% | -$190.0K |
| D | 2022-08-15 | 2022-08-11 | FHTX | Foghorn Therapeutics Inc. | Bellon Steven F. | CSO | M - OptEx | $3.72 | +1,858 | 122.0K | +2% | +$6,912 |
| DM | 2022-05-27 | 2022-05-25 | FHTX | Foghorn Therapeutics Inc. | Bellon Steven F. | CSO | M - OptEx | $3.26 | +4,392 | 120.1K | +4% | +$14.3K |
Purchase Sale Sale after option exercise All abbreviations